Skip to content

POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy

POMDOCTOR LIMITED has begun preparations for entering the U.S. market as part of its global growth strategy. The company is focusing on recruitment for leadership roles, assessing the healthcare market, and structuring compliance frameworks. Their approach includes pilot validation for remote patient monitoring and chronic disease management, leveraging their AI-driven healthcare platform and physician network to improve healthcare outcomes. CEO Zhenyang Shi stated that this expansion will serve as a foundational pillar for future growth into additional markets.

GUANGZHOU, China, Aug. 27, 2026 /PRNewswire/ — POMDOCTOR LIMITED (“Pomdoctor” or the “Company”) (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today announced the formal initiation of its U.S. market entry preparations, marking a…